Quantcast

Latest Vancomycin Stories

2010-06-21 05:55:00

EXTON, Pa., June 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today provided an update on recent progress in Cinryze(TM) (C1 Esterase Inhibitor [Human]) manufacturing expansion activities. ViroPharma is increasing its Cinryze manufacturing capacity through two concurrent efforts. The first project, the parallel chromatography process, was implemented earlier this year and allows production to run across multiple shifts, effectively doubling the capacity of the...

2010-06-14 07:31:00

CHICAGO, June 14 /PRNewswire-USNewswire/ -- MRSA Survivors Network with MRSA survivors, family members and other victims of healthcare-acquired infections unite across the globe and on World MRSA Day, October 2, 2010 in a grassroots movement to raise awareness and push for more mandated reporting of infections, MRSA screening laws, funds to raise awareness and educate the public on prevention, which will save lives. (Logo: http://photos.prnewswire.com/prnh/20090825/DC65136LOGO ) Jeanine...

2010-06-03 14:00:00

EXTON, Pa., June 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Jefferies 2010 Global Life Sciences Conference at 4:00 P.M. ET on Wednesday, June 9, 2010. The conference is being held at the Grand Hyatt in New York City. Mr. Roberts also will present at the ThinkEquity Healthcare Conference at 1:30 P.M. ET on Wednesday, June 16, 2010. The conference is...

2010-05-27 17:33:02

Researchers shed light on the mode of action; promising approach for new antibiotics An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this. The authors see plectasin as a promising...

2010-05-24 08:00:00

WOBURN, Mass., May 24 /PRNewswire/ -- AdvanDx today announced that it will offer the BinaxNOW® PBP2a test from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the United States. The test provides rapid detection of the penicillin-binding protein 2a (PBP2a) present in Methicillin-Resistant Staphylococcus aureus (MRSA) directly from S. aureus positive blood cultures. In clinical studies, the test demonstrated 97.1% positive agreement and 100% negative...

bd484c2ee37388d1c318efa880c1bd501
2010-05-17 11:25:00

A study recently published has found that the number of children hospitalized with dangerous drug-resistant staph infections surged 10-fold in recent years. The study showed that disease incidence increased from 2 cases to 21 cases per 1,000 hospital admissions from 1999 to 2008.  Most of the infections were caught in the community, not in the hospital. The study involved methicillin-resistant infections, called MRSA.  These used to occur more often in hospitals and nursing homes,...

2010-05-10 20:51:00

SEOUL, South Korea, May 10 /PRNewswire/ -- CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe. CG400549 is a potential first-in-class antibiotic candidate targeting ENR (Enoyl-acyl carrier protein reductase, which is a critical enzyme in generating bacterial membrane) as it has novel chemical structure which has never been used as an...

2010-05-04 14:15:00

SAN DIEGO, May 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced the presentation of new data from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection (CDI). The data, presented by Stuart Johnson, M.D. during an oral session at the annual meeting of Digestive Disease Week (DDW) in New Orleans, indicated that treatment with fidaxomicin significantly improved the recurrence rate and global cure rate in CDI patients...

2010-04-30 13:30:00

EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Deutsche Bank 35th Annual Healthcare Conference at 1:30 P.M. ET on Tuesday, May 4, 2010. The conference is being held at the InterContinental Hotel in Boston. Vincent Milano, president and chief executive officer, of ViroPharma, will present at the Bank of America/Merrill Lynch 2010...

2010-04-27 06:30:00

EXTON, Pa., April 27 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that it has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze(TM) (C1 esterase inhibitor [human)] in 24 adolescents and adult subjects with hereditary angioedema (HAE). Cinryze was approved by the U.S. Food and Drug Administration in October 2008 for routine...


Latest Vancomycin Reference Libraries

0_4d46cc72a490344d44ba78359f528175
2011-04-26 21:07:20

Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...

0_71ad70ea6f0948a7e84406e760c7f5a4
2011-04-15 14:36:05

Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...

More Articles (2 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related